1 recruiting, 1 unknown. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Cilazapril: new trials by email Literature Review of Cilazapril trials Research Report on Cilazapril
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients RAS-antagonist and beta-blocker up-to maximal dosages, RAS-antagonist and beta-blocker none or at stable dose - Heart Diseases, Diabetes Mellitus, Type 2 | Phase 4 | Recruiting | Martin Huelsmann | 2400 | 2016-02-01 | 2023-03-14 |
| ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT prednisone + Inhibace/Cozaar, Inhibace/Cozaar - Glomerulonephritis, IGA | Not applicable | Unknown | Peking University | 2006-01-01 | 2006-09-22 |
Diabetes Mellitus, Type 2 (1) · Glomerulonephritis, IGA (1) · Heart Diseases (1)
Martin Huelsmann (1) · Peking University (1)
Austria (1) · Netherlands (1) · New Zealand (1) · Spain (1) · United Kingdom (1)
Hong Zhang, MD (1) · Martin Huelsmann, Doz.Dr. (1)